Related Experiment Video
Updated: Aug 5, 2025
09:35
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
13.3K
Dynamics of Hepatitis B Virus Covalently Closed Circular DNA: A Mini-Review
1Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Microorganisms
|March 29, 2023
Summary
Eradicating hepatitis B virus cccDNA requires understanding its half-life, influenced by host cell turnover and therapy. This review analyzes factors affecting cccDNA decay and proposes strategies for chronic hepatitis B treatment.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Chronic hepatitis B (CHB) therapy aims to eliminate cccDNA, the viral DNA form persisting in hepatocytes.
- Understanding cccDNA dynamics, particularly its half-life, is crucial for developing effective CHB treatment strategies.
- cccDNA half-life is not an intrinsic property but reflects host cell factors and viral clearance mechanisms.
Purpose of the Study:
- To analyze key factors influencing cccDNA half-life in CHB.
- To identify research gaps concerning cccDNA decay mechanisms.
- To explain discrepancies in cccDNA half-life observed during nucleot(s)ide analog (NUC) therapy.
Main Methods:
- Literature review and analysis of existing data on cccDNA dynamics.
- Examination of host cell factors, including hepatocyte turnover and noncytopathic effects.
- Evaluation of NUC therapy's impact on cccDNA pool decline.
Main Results:
- cccDNA decay is primarily driven by hepatocyte turnover and noncytopathic effects.
- Observed discrepancies in cccDNA half-life exist between short-term and long-term NUC treatments.
- Multi-phasic decline patterns of cccDNA during NUC therapy require further investigation.
Conclusions:
- Hepatocyte lifespan significantly impacts cccDNA half-life, often more than cccDNA intrinsic properties.
- Further research is needed to elucidate the complex factors governing cccDNA decay.
- A framework based on cccDNA dynamics can guide the development of novel anti-HBV strategies.
